Arbutus Biopharma Corp Net Income per Employee (ABUS), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Arbutus Biopharma Corp  (NASDAQ: ABUS)
 

Arbutus Biopharma Net Income per Employee

ABUS's Quarterly Results, Trends, Rankings, Statistics
Arbutus Biopharma's Income per employee grew in the first quarter 2026 on a trailing twelve month basis to $ 8,458,947, the income was higher than average, indicating higher productivity of the company's employees.
The Healthcare sector has seen employees of 3 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 29, from total ranking in previous quarter at 3837.


What is Income per Employee Ratio?






ABUS Net Income per Employee (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 8,458,947 -1,763,211 -5,905,105 -6,535,368 -7,710,053
ABUS's Total Ranking # 29 # 3837 # 3517 # 3756 #
Seq. Net Income Change - - - - -


ABUS Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 4
Healthcare Sector # 4
Overall Market # 29

Net Income per Employee Statistics
High Average Low
$ 9,629,474 $ -4,937,378 $ -20,364,053
(Mar 31 2026)   (Mar 31 2017)







Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026
Royalty Pharma Plc  13,590,150.00 $ 1,359.015  Million 100 
Vertex Pharmaceuticals Inc  10,711,851.85 $ 4,338.300  Million 405 
Oramed Pharmaceuticals Inc  8,459,076.92 $ 109.968  Million 13 
Arbutus Biopharma Corp  8,458,947.37 $ 160.720  Million 19 
Oncotelic Therapeutics Inc   6,503,944.82 $ 247.150  Million 38 


Date modified: 2026-06-24T02:44:34+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.